Physician profile
Lloyd Huang
NPI 1598871642
$1,666.10
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,437 · 2020: $229.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $324.49 | 2019-2020 | |
| Novo Nordisk INC | $272.15 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $185.18 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $178.76 | 2019 | |
| Glaxosmithkline, LLC. | $172.38 | 2019-2020 | |
| Amgen INC. | $109.00 | 2019-2020 | |
| Pfizer INC. | $66.70 | 2019 | |
| Astellas Pharma US INC | $66.16 | 2019 | |
| Lilly USA, LLC | $59.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $52.90 | 2019 | |
| Arbor Pharmaceuticals, INC. | $41.08 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.87 | 2019 | |
| Merck Sharp & Dohme LLC | $26.17 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.09 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $16.19 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15.66 | 2019 | |
| Allergan, INC. | $12.18 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.68 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lloyd Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.